Incident 2day
Mumbai based pharmaceutical company, Wockhardt has revealed that it has got a tentative approval from the US Food and Drug Administration to market its generic copy of Aricept tablets used in treatment of Alzheimer’s and dementia.
Wockhardt said that it expects to launch the Donepezil HCl tablets by May 8 this year and added that the approval has been given for 5 mg and 10 mg versions of the tablet.
The company is confident of getting a substantial slice of the $2.5 billion market that the drug commands in the US.
“We are continuing to get a steady stream of FDA approval and are able to launch them on the date the generic market opportunity opens”, the company chairman, Mr Habil Khorakiwala said.
Wockhardt said that it expects to launch the Donepezil HCl tablets by May 8 this year and added that the approval has been given for 5 mg and 10 mg versions of the tablet.
The company is confident of getting a substantial slice of the $2.5 billion market that the drug commands in the US.
“We are continuing to get a steady stream of FDA approval and are able to launch them on the date the generic market opportunity opens”, the company chairman, Mr Habil Khorakiwala said.
Posted in: Health
0 comments:
Post a Comment